Industry

WALTHAM, Mass.–(BUSINESS WIRE)–Palleon Pharmaceuticals, a clinical-stage company pioneering glyco-immunology drug development to treat cancer and inflammatory diseases, today announced that the company will present at the Oppenheimer Healthcare Private Company Showcase: The Next Wave on Tuesday, October 18, 2022. Jim Broderick, M.D., Chief Executive Officer and founder of Palleon, will present a company overview at … [Read more…]

Veteran biotech executive brings decades of commercialization and operations experience MEDFORD, Mass.–(BUSINESS WIRE)–#Diagnostics—Torus Biosystems (“Torus” or the “Company”), the company pioneering molecular in vitro diagnostics for point of care use, today announced the appointment of Nancy Hill as lead Independent Director to the Company’s Board of Directors. Ms. Hill will also serve as a member … [Read more…]

The three-year commitment will address increases in youth mental health challenges revealed by the 2022 America’s Health Rankings® Health of Women and Children Report. MINNETONKA, Minn.–(BUSINESS WIRE)–The United Health Foundation, the philanthropic foundation of UnitedHealth Group (NYSE: UNH), is making a $3 million commitment over three years in partnership with Active Minds, a leading nonprofit … [Read more…]

Results from CHAMPION-NMOSD trial demonstrated zero relapses with a median treatment duration of 73 weeks Additional presentations will underscore debilitating emotional and physical toll of NMOSD on patients and caregivers, and highlight urgency to reduce disease burden WILMINGTON, Del.–(BUSINESS WIRE)–Alexion, AstraZeneca Rare Disease, will present new data showing significant advances for the treatment of anti-aquaporin-4 … [Read more…]

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) plans to announce its operating results for the quarter ended September 30, 2022 before the market opens on Thursday, November 3, 2022, and will host a conference call at 8:00 a.m. CT (9:00 a.m. ET) that day to discuss those results. Click here to access the … [Read more…]

More than 2 Billion People Suffer from Myopia (Nearsightedness) Globally1; Max Strus Teams Up with STAAR Surgical to Inspire Athletes of All Levels and Others to Take a Shot at Visual Freedom LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the … [Read more…]

– Fundraising led by Cambrian BioPharma and Solve FSHD – – Company expands pipeline with new program, VTA-120, for the treatment of facioscapulohumeral muscular dystrophy (FSHD) – BALTIMORE–(BUSINESS WIRE)–Vita Therapeutics, a cell engineering company harnessing the power of genetics to develop novel cellular therapies to treat muscular dystrophies and cancers, today announced the completion of … [Read more…]

CRANBURY, N.J.–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with high unmet need, today announces data presentations at the 29th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT) in Edinburgh, United Kingdom, taking place October … [Read more…]

– Dr. Countouriotis brings nearly two decades of leadership experience across pharmaceutical and biotechnology companies, leading the development of multiple oncology programs through approval – Michael Rosenzweig, DVM, Ph.D., appointed Executive Vice President, Portfolio Strategy and Product Development SAN DIEGO & PHILADELPHIA–(BUSINESS WIRE)–Capstan Therapeutics, Inc., a biotechnology company dedicated to developing and delivering precise in … [Read more…]

Tissue from non-small cell lung cancer and breast cancer mapped at single-cell and subcellular resolution SEATTLE–(BUSINESS WIRE)–#spatialbiology–NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the publication of its first paper describing the CosMx™ Spatial Molecular Imager’s (SMI) chemistry, reproducibility, and sensitivity, as well as … [Read more…]